QHSLab, Inc. (USAQ)
QHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors. Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms. The firm also develops digital therapeutic solutions and on-site technologies intended for remote patient oversight, the management of chronic conditions, and proactive health maintenance. Among its offerings is a proprietary cloud-based SaaS platform, also known as QHSLab (Quality Health Score Lab expert system). This system empowers physicians and healthcare organizations to securely record and store electronic patient data. Additionally, QHSLab, Inc. acts as a distributor, providing primary care physicians with AllergiEnd, a product line encompassing diagnostic tools and allergen immunotherapy treatments. All of its solutions are strategically designed to aid in the prevention, early identification, effective management, and potential reversal of chronic diseases. The company was established in 1983 and is headquartered in West Palm Beach, Florida. It operated under the name USA Equities Corp. until April 2022, when it officially rebranded to QHSLab, Inc. The company also maintains a strategic partnership with Medical License Factory, LLC.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
QHSLab, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 15.03M shares outstanding
USQHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors.
Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms.
The firm also develops digital therapeutic solutions and on-site technologies intended for remote patient oversight, the management of chronic conditions, and proactive health maintenance. Among its offerings is a proprietary cloud-based SaaS platform, also known as QHSLab (Quality Health Score Lab expert system). This system empowers physicians and healthcare organizations to securely record and store electronic patient data.
Additionally, QHSLab, Inc. acts as a distributor, providing primary care physicians with AllergiEnd, a product line encompassing diagnostic tools and allergen immunotherapy treatments. All of its solutions are strategically designed to aid in the prevention, early identification, effective management, and potential reversal of chronic diseases.
The company was established in 1983 and is headquartered in West Palm Beach, Florida.
It operated under the name USA Equities Corp. until April 2022, when it officially rebranded to QHSLab, Inc.
The company also maintains a strategic partnership with Medical License Factory, LLC.
Leadership
Cyndi Cole
Financial Controller
Olivia Giamanco
Marketing Director
Troy James Grogan
Chief Executive Officer, Chief Financial Officer, President & Chairman
Employees
4
Country
US
Sector
Healthcare
Website
usaqcorp.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Marvin Smollar Family Trust dtd 2/13/2023 | 10% Owner | Grant/Award | 2.23M | -- | Aug 26, 2026 |
 Grogan Troy James | President and CEO | Conversion of Derivative | 213.1K | $38.5K | Dec 31, 2024 |
| Grogan Troy James | President and CEO | Other | 2.64M | $756.51B | Dec 31, 2021 |
| Grogan Troy James | President and CEO | Other | 1.08M | $276.16B | Sep 1, 2019 |
| Name | Shares | % | Source |
|---|---|---|---|
 Grogan Troy James President and CEO, Director, 10% Owner | 3.9M | 25.9% | FORM 4 |
Jeremy L. Smollar Irrevocable Trust dtd 2/13/2023 · joint filing· may incl. warrants· filed Sep 2026 | 1.1M | 7.4% | 13G |
Justin B. Smollar Irrevocable Trust dtd 2/13/2023 · joint filing· may incl. warrants· filed Sep 2026 | 1.1M | 7.4% | 13G |
Insiders
- Marvin Smollar Family Trust dtd 2/13/202310% Owner
- Grogan Troy JamesPresident and CEO
based on 15.03M shares outstanding
US30d Avg
4.22K
60d Avg
5.85K
90d Avg
6.17K